- Home
- ZEO vs ANVS Comparison
ZEO vs ANVS Comparison
Compare ZEO & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZEO
- ANVS
- Stock Information
- Founded
- ZEO 2005
- ANVS 2008
- Country
- ZEO United States
- ANVS United States
- Employees
- ZEO N/A
- ANVS N/A
- Industry
- ZEO
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- ZEO
- ANVS Health Care
- Exchange
- ZEO NYSE
- ANVS Nasdaq
- Market Cap
- ZEO 22.5M
- ANVS 24.2M
- IPO Year
- ZEO N/A
- ANVS 2020
- Fundamental
- Price
- ZEO $2.72
- ANVS $3.21
- Analyst Decision
- ZEO
- ANVS Strong Buy
- Analyst Count
- ZEO 0
- ANVS 5
- Target Price
- ZEO N/A
- ANVS $34.75
- AVG Volume (30 Days)
- ZEO 5.4M
- ANVS 593.2K
- Earning Date
- ZEO 06-17-2025
- ANVS 05-13-2025
- Dividend Yield
- ZEO N/A
- ANVS N/A
- EPS Growth
- ZEO N/A
- ANVS N/A
- EPS
- ZEO N/A
- ANVS N/A
- Revenue
- ZEO $73,244,083.00
- ANVS N/A
- Revenue This Year
- ZEO N/A
- ANVS N/A
- Revenue Next Year
- ZEO N/A
- ANVS N/A
- P/E Ratio
- ZEO N/A
- ANVS N/A
- Revenue Growth
- ZEO N/A
- ANVS N/A
- 52 Week Low
- ZEO $1.05
- ANVS $1.11
- 52 Week High
- ZEO $4.75
- ANVS $17.88
- Technical
- Relative Strength Index (RSI)
- ZEO 61.23
- ANVS 75.97
- Support Level
- ZEO $2.52
- ANVS $1.95
- Resistance Level
- ZEO $3.05
- ANVS $3.48
- Average True Range (ATR)
- ZEO 0.28
- ANVS 0.29
- MACD
- ZEO 0.10
- ANVS 0.11
- Stochastic Oscillator
- ZEO 61.73
- ANVS 84.57
About ZEO ZEO ENERGY CORP
Zeo Energy Corp is a vertically integrated provider of residential solar energy systems, other energy efficient equipment and related services currently serving customers in Florida, Texas, Arkansas, and Missouri. Its primary business activity is selling and installing residential solar energy systems that homeowners use to supplement the amount of usable electricity required to power their homes.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.